SCHEMBL2940909

SCHEMBL2940909

S=C=NCc1c[nH]c2ccccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.56
KMT2A Q03164 5/20 0.56
CYP3A4 P08684 3/20 0.56
MAPT P10636 3/20 0.56
AHR P35869 1/20 0.56
GPR84 Q9NQS5 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
HTR2A P28223 4/20 0.50
CYP2D6 P10635 3/20 0.50
HTR2C P28335 3/20 0.50
HTR6 P50406 3/20 0.50
HTR1D P28221 2/20 0.50
HTR1B P28222 2/20 0.50
HTR7 P34969 2/20 0.50
MPO P05164 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2A6 P11509 1/20 0.50
NFKB1 P19838 1/20 0.50
CTSK P43235 1/20 0.50
CYP2A13 Q16696 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6353772 0.83 HTR2A (0.56) MEN1KMT2ACYP3A4MAPTAHR
SCHEMBL9664786 0.83 MEN1 (0.56) MEN1KMT2ACYP3A4MAPTAHR
SCHEMBL18595374 0.80 MEN1 (0.49) MEN1KMT2ACYP3A4MAPTAHR
SCHEMBL30484245 0.79 HTR2A (0.59) MEN1KMT2AMAPTGPR84TDP1
SCHEMBL4102821 0.79 HTR2A (0.59) MEN1KMT2AMAPTGPR84TDP1
SCHEMBL28224556 0.77 MEN1 (0.62) MEN1KMT2ACYP3A4MAPTAHR
SCHEMBL14254667 0.73 HTR2A (0.59) MEN1KMT2ACYP3A4MAPTAHR
SCHEMBL4985934 0.73 HTR2A (0.77) MEN1KMT2ACYP3A4MAPTAHR
Arundine SCHEMBL325162 0.73 MEN1 (1.00) MEN1KMT2ACYP3A4MAPTAHR
SCHEMBL29616337 0.72 MIF (0.62) CYP3A4CYP2A6CYP2A13ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100260737-A1 COMBINATION BETWEEN AN ISOTHIOCYANATE AND LEVODOPA FOR PARKINSON'S DISEASE TREATMENT ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA (IT) 2010-10-14 US claimed
EP-2229166-A1 COMBINATION BETWEEN AN ISOTHIOCYANATE AND LEVODOPA FOR PARKINSON'S DISEASE TREATMENT Alma Mater Studiorum - Università di Bologna (IT) 2010-09-22 EP claimed
US-20100086658-A1 LOW FAT CONSUMER PRODUCT COMPRISING A NATURAL PRESERVATIVE SYSTEM AND A METHOD FOR MAKING THE SAME CONOPCO, INC. D/B/A UNILEVER 2010-04-08 US claimed
EP-2163238-A2 Compound for lightening skin tone comprising sulforaphane or sulforaphene or their derivates Henkel AG & Co. KGaA (DE) 2010-03-17 EP claimed
US-20090326056-A1 NOVEL ACTIVES AGAINST PROSTATE CARCINOMA DSM IP ASSETS B.V. (NL) 2009-12-31 US claimed
EP-2120611-A1 A LOW FAT CONSUMER PRODUCT COMPRISING A NATURAL PRESERVATIVE SYSTEM AND A METHOD FOR MAKING THE SAME UNILEVER N.V. (NL) 2009-11-25 EP claimed
EP-1569628-B1 NOVEL USE OF LYCOPENE FOR THE TREATMENT OF DISEASES ASSOCIATED WITH ANDROGEN SIGNALLING DSM IP ASSETS BV (NL) 2009-07-22 EP claimed
WO-2009083871-A1 COMBINATION BETWEEN AN ISOTHIOCYANATE AND LEVODOPA FOR PARKINSON'S DISEASE TREATMENT ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA (IT) 2009-07-09 WO claimed
EP-2020997-A2 NOVEL ACTIVES AGAINST PROSTATE CARCINOMA DSMIP Assets B.V. (NL) 2009-02-11 EP claimed
WO-2008098804-A1 A LOW FAT CONSUMER PRODUCT COMPRISING A NATURAL PRESERVATIVE SYSTEM AND A METHOD FOR MAKING THE SAME UNILEVER N.V. (NL) 2008-08-21 WO claimed
US-20080193615-A1 LOW FAT CONSUMER PRODUCT COMPRISING A NATURAL PRESERVATIVE SYSTEM AND A METHOD FOR MAKING THE SAME CONOPCO, INC., D/B/A UNILEVER (US) 2008-08-14 US claimed
WO-2007131767-A2 NOVEL ACTIVES AGAINST PROSTATE CARCINOMA DSM IP ASSETS B.V. (NL) 2007-11-22 WO claimed
US-20060069151-A1 Novel use of lycopene DSM IP ASSETS B.V. (NL) 2006-03-30 US claimed
US-20060020046-A1 Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies DMS IP ASSETS B.V. (NL) 2006-01-26 US claimed
EP-1569628-A1 NOVEL USE OF LYCOPENE DSM IP Assets B.V. (NL) 2005-09-07 EP claimed
EP-1476143-A1 COMPOSITIONS COMPRISING LYCOPENE FOR THE TREATMENT AND PREVENTION OF ANGIOGENESIS ASSOCIATED PATHOLOGIES DSM IP Assets B.V. (NL) 2004-11-17 EP claimed
WO-2004052351-A1 NOVEL USE OF LYCOPENE DSM IP ASSETS B.V. (CH) 2004-06-24 WO claimed
WO-2003068202-A1 COMPOSITIONS COMPRISING LYCOPENE FOR THE TREATMENT AND PREVENTION OF ANGIOGENESIS ASSOCIATED PATHOLOGIES DSM IP ASSETS B.V. (NL) 2003-08-21 WO claimed
US-20250197898-A1 ISOTHIOCYANATE CONTAINING BRASSICACEAE PRODUCTS AND METHOD OF PREPARATION THEREOF COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2025-06-19 US disclosed
WO-2001035769-A1 PRODUCTS COMPRISING AN ISOTHIOCYANATE PRESERVATIVE SYSTEM AND METHODS OF THEIR USE THE PROCTER & GAMBLE COMPANY (US) 2001-05-25 WO disclosed